BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 17850827)

  • 1. Plasma lysophosphatidic acid level and serum autotaxin activity are increased in liver injury in rats in relation to its severity.
    Watanabe N; Ikeda H; Nakamura K; Ohkawa R; Kume Y; Tomiya T; Tejima K; Nishikawa T; Arai M; Yanase M; Aoki J; Arai H; Omata M; Fujiwara K; Yatomi Y
    Life Sci; 2007 Sep; 81(12):1009-15. PubMed ID: 17850827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C.
    Watanabe N; Ikeda H; Nakamura K; Ohkawa R; Kume Y; Aoki J; Hama K; Okudaira S; Tanaka M; Tomiya T; Yanase M; Tejima K; Nishikawa T; Arai M; Arai H; Omata M; Fujiwara K; Yatomi Y
    J Clin Gastroenterol; 2007 Jul; 41(6):616-23. PubMed ID: 17577119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical introduction of lysophosphatidic acid and autotaxin assays].
    Yatomi Y
    Rinsho Byori; 2010 Jun; 58(6):631-5. PubMed ID: 20662276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the properties of a selective, orally bioavailable autotaxin inhibitor in preclinical models of advanced stages of liver fibrosis.
    Baader M; Bretschneider T; Broermann A; Rippmann JF; Stierstorfer B; Kuttruff CA; Mark M
    Br J Pharmacol; 2018 Feb; 175(4):693-707. PubMed ID: 29197066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autotaxin in liver fibrosis.
    Ikeda H; Yatomi Y
    Clin Chim Acta; 2012 Nov; 413(23-24):1817-21. PubMed ID: 22820036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of autotaxin, an ectoenzyme that produces lysophosphatidic acid, in human placenta.
    Iwasawa Y; Fujii T; Nagamatsu T; Kawana K; Okudaira S; Miura S; Matsumoto J; Tomio A; Hyodo H; Yamashita T; Oda K; Kozuma S; Aoki J; Yatomi Y; Taketani Y
    Am J Reprod Immunol; 2009 Aug; 62(2):90-5. PubMed ID: 19614625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the placenta in serum autotaxin elevation during maternal cholestasis.
    Macias RIR; Matilla S; Lozano E; Estiú MC; Oude Elferink RP; Marin JJG
    Am J Physiol Gastrointest Liver Physiol; 2018 Sep; 315(3):G399-G407. PubMed ID: 29927323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autotaxin-lysophosphatidic acid receptor signalling regulates hepatitis C virus replication.
    Farquhar MJ; Humphreys IS; Rudge SA; Wilson GK; Bhattacharya B; Ciaccia M; Hu K; Zhang Q; Mailly L; Reynolds GM; Ashcroft M; Balfe P; Baumert TF; Roessler S; Wakelam MJO; McKeating JA
    J Hepatol; 2017 May; 66(5):919-929. PubMed ID: 28126468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development.
    van Meeteren LA; Ruurs P; Stortelers C; Bouwman P; van Rooijen MA; Pradère JP; Pettit TR; Wakelam MJ; Saulnier-Blache JS; Mummery CL; Moolenaar WH; Jonkers J
    Mol Cell Biol; 2006 Jul; 26(13):5015-22. PubMed ID: 16782887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autotaxin activity increases locally following lung injury, but is not required for pulmonary lysophosphatidic acid production or fibrosis.
    Black KE; Berdyshev E; Bain G; Castelino FV; Shea BS; Probst CK; Fontaine BA; Bronova I; Goulet L; Lagares D; Ahluwalia N; Knipe RS; Natarajan V; Tager AM
    FASEB J; 2016 Jun; 30(6):2435-50. PubMed ID: 27006447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher LPA2 and LPA6 mRNA Levels in Hepatocellular Carcinoma Are Associated with Poorer Differentiation, Microvascular Invasion and Earlier Recurrence with Higher Serum Autotaxin Levels.
    Enooku K; Uranbileg B; Ikeda H; Kurano M; Sato M; Kudo H; Maki H; Koike K; Hasegawa K; Kokudo N; Yatomi Y
    PLoS One; 2016; 11(9):e0161825. PubMed ID: 27583415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexamethasone decreases the autotaxin-lysophosphatidate-inflammatory axis in adipose tissue: implications for the metabolic syndrome and breast cancer.
    Meng G; Tang X; Yang Z; Zhao Y; Curtis JM; McMullen TPW; Brindley DN
    FASEB J; 2019 Feb; 33(2):1899-1910. PubMed ID: 30192654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of the Lysophosphatidylcholine/Autotaxin/Lysophosphatidic Acid Axis in Acute-on-Chronic Liver Failure Is Associated With Mortality and Systemic Inflammation by Lysophosphatidic Acid-Dependent Monocyte Activation.
    Trovato FM; Zia R; Napoli S; Wolfer K; Huang X; Morgan PE; Husbyn H; Elgosbi M; Lucangeli M; Miquel R; Wilson I; Heaton ND; Heneghan MA; Auzinger G; Antoniades CG; Wendon JA; Patel VC; Coen M; Triantafyllou E; McPhail MJ
    Hepatology; 2021 Aug; 74(2):907-925. PubMed ID: 33908067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATX-LPA axis induces expression of OPN in hepatic cancer cell SMMC7721.
    Zhang R; Zhang Z; Pan X; Huang X; Huang Z; Zhang G
    Anat Rec (Hoboken); 2011 Mar; 294(3):406-11. PubMed ID: 21337710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autotaxin/lysopholipase D and lysophosphatidic acid regulate murine hemostasis and thrombosis.
    Pamuklar Z; Federico L; Liu S; Umezu-Goto M; Dong A; Panchatcharam M; Fulkerson Z; Berdyshev E; Natarajan V; Fang X; van Meeteren LA; Moolenaar WH; Mills GB; Morris AJ; Smyth SS
    J Biol Chem; 2009 Mar; 284(11):7385-94. PubMed ID: 19139100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for de novo synthesis of lysophosphatidic acid in the spinal cord through phospholipase A2 and autotaxin in nerve injury-induced neuropathic pain.
    Ma L; Uchida H; Nagai J; Inoue M; Aoki J; Ueda H
    J Pharmacol Exp Ther; 2010 May; 333(2):540-6. PubMed ID: 20123931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The Laboratory Medicine of Lipid Mediators].
    Yatomi Y
    Rinsho Byori; 2015 Oct; 63(10):1183-6. PubMed ID: 26897854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer cell expression of autotaxin controls bone metastasis formation in mouse through lysophosphatidic acid-dependent activation of osteoclasts.
    David M; Wannecq E; Descotes F; Jansen S; Deux B; Ribeiro J; Serre CM; Grès S; Bendriss-Vermare N; Bollen M; Saez S; Aoki J; Saulnier-Blache JS; Clézardin P; Peyruchaud O
    PLoS One; 2010 Mar; 5(3):e9741. PubMed ID: 20305819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of serum autotaxin activity in gastrointestinal disease].
    Ikeda H; Watanabe N; Nakamura K; Kume Y; Nakai Y; Fujishiro M; Omata M; Igarashi K; Yokota H; Yatomi Y
    Rinsho Byori; 2009 May; 57(5):445-9. PubMed ID: 19522250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel autotaxin inhibitor reduces lysophosphatidic acid levels in plasma and the site of inflammation.
    Gierse J; Thorarensen A; Beltey K; Bradshaw-Pierce E; Cortes-Burgos L; Hall T; Johnston A; Murphy M; Nemirovskiy O; Ogawa S; Pegg L; Pelc M; Prinsen M; Schnute M; Wendling J; Wene S; Weinberg R; Wittwer A; Zweifel B; Masferrer J
    J Pharmacol Exp Ther; 2010 Jul; 334(1):310-7. PubMed ID: 20392816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.